Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Optic Nerve Glioma × Vincristine × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 98 Lymphoma, Large B-Cell, Diffuse 70 Precursor Cell Lymphoblastic Leukemia-Lymphoma 58 Leukemia 41 Burkitt Lymphoma 39 Lymphoma, Non-Hodgkin 31 Lymphoma, Mantle-Cell 27 Lymphoma, Follicular 26 Hodgkin Disease 20 Sarcoma 16 Central Nervous System Neoplasms 15 Neuroblastoma 14 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma, B-Cell 11 Lymphoma, Large-Cell, Anaplastic 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, T-Cell, Peripheral 9 Dendritic Cell Sarcoma, Interdigitating 9 Sarcoma, Ewing 8 Neoplasms 8 Lymphoma, B-Cell, Marginal Zone 8 Neuroectodermal Tumors, Primitive, Peripheral 7 Multiple Myeloma 7 Medulloblastoma 7 Rhabdomyosarcoma 6 Retinoblastoma 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Leukemia, Biphenotypic, Acute 6 HIV Infections 6 Wilms Tumor 5

Interventions

Carboplatin 3 etoposide phosphate 1 becatecarin 1 Vincristine 1 Temozolomide 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 RMP 7 1 Perfusion Magnetic Resonance Imaging 1 Oxaliplatin 1 Megestrol Acetate 1 Lenalidomide 1 Irinotecan 1 Immunologic Techniques 1 Etoposide 1 Endostatins 1 Dynamic Contrast Enhanced Magnetic Resonance Imaging 1 Doxorubicin 1 Cyproheptadine 1 Cilengitide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05278715 2024-10-15

Modified CV Regimen in Optic Pathway Glioma

Beijing Sanbo Brain Hospital

Phase 2 Recruiting

Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡